Why these pot stocks are moving higher

Pot stocks continue to provide investors with strong returns…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Amid regulatory changes and positive developments for both the medical and recreational marijuana industries ASX pot stocks continue to climb higher.

Here are some companies that posted gains on Tuesday.

Hydroponics Company Ltd (ASX: THC)

The Hydroponics Company Ltd saw its share price gain more than 8 per cent on Tuesday as the company released a positive business update.

Shares in the Hydroponics Company are now trading for about 98.5 cents, having gained more than 140 per cent over the past year.

The company, with a market value of about $72 million, stated that it is proceeding with plans to alter its business model.

The Hydroponics Company intends to develop an end-to-end pharma service and product delivery capability, incorporating research and development, growing and manufacturing, importation, and clinical trials.

The company was previously focussed on medicinal cannabis and the manufacturing and distribution of hydroponics equipment.

But recent regulatory changes appear to have motivated the company to expand its repertoire.

Medlab Clinical Ltd (ASX: MDC)

The Medlab share price was up again, gaining about 1.4 per to add to a yearly return that now exceeds 30 per cent.

Medlab's Australian manufactured cannabis product is expected to be available this month.

The company, with a market cap of about $191 million, recently announced it received a licence to sell its cannabis-based products NanaBis and NanaBidial.

Medlab shares are now trading for about $1.07.

Creso Pharma Ltd (ASX: CPH)

The Creso Pharma Ltd share price was up slightly, gaining almost 0.5 per cent, with its shares now trading for about $1.07.

Creso Pharma shareholders have enjoyed staggering returns exceeding 400 per cent over the past year.

The company, with a market value of around $92 million, this month announced that it plans to launch a cannabis drink.

The first batch is set to be shipped in the next few months with sales expected to commence by September.

Motley Fool contributor Steve Holland has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »